Lytix Biopharma and UiT with exclusive agreement
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).
Wenche Gerhardsen is Head of Communications at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator. You can reach her at wg@oslocancercluster.no
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).
Dette er endringene i eierstrukturen for Oslo Cancer Cluster (OCC) Innovasjonspark i januar 2020.
Kaare R. Norum died on Friday 22 November 2019, at an age of 86 years.
Næringskomiteens innstilling om Helsenæringsmeldingen er klar. Dette mener Oslo Cancer Cluster om tre viktige temaer i innstillingen.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.